AdaptHealth (AHCO) Cash from Operations Growth (5y) (2023 - 2026)
AdaptHealth (AHCO) Cash from Operations Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn |
| 2 | Stryker | 128.94 Bn | 126.06 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.65 Bn | 67.19 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.10 Bn | 21.98 Bn | 2.07 Bn |
| 10 | AdaptHealth | 1.51 Bn | 1.46 Bn | 111.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.52% |
| Dec 31, 2025 | 29.47% |
| Sep 30, 2025 | 36.27% |
| Jun 30, 2025 | 13.34% |
| Mar 31, 2025 | 31.41% |
| Dec 31, 2024 | 54.22% |
| Sep 30, 2024 | 53.15% |
| Jun 30, 2024 | 82.41% |
| Mar 31, 2024 | 24.75% |
| Dec 31, 2023 | 17.37% |
| Sep 30, 2023 | 208.47% |
| Jun 30, 2023 | 177.27% |
| Mar 31, 2023 | 226.47% |